Current Affairs

Inebilizumab Calms Flares in IgG4-RD With Pancreas or Hepatobiliary Involvement

(MedPage Today)-Less treatment for IGG4-RD (UPLIZNA) from the risk of glow in patients with IGG4 (IGG4-RD) with participation in the pancreas, bile ducts, or liver, according to post-challenge analysis …

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button